Covered recipient · General Payments record
INDIA K ROBINSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,755.18
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $306.60 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $56.15 | 3 |
| SANOFI-AVENTIS U.S. LLC | $47.91 | 2 |
| Novo Nordisk AS | $42.17 | 2 |
| Lilly USA, LLC | $38.78 | 2 |
| Amgen Inc. | $34.67 | 2 |
| ABBVIE INC. | $34.24 | 2 |
| PFIZER INC. | $33.29 | 1 |
| SHIELD THERAPEUTICS INC | $19.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.75 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959746 | CMS |
| ABBVIE INC. | $13.49 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959748 | CMS |
| Amgen Inc. | $18.57 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111689940 | CMS |
| Amgen Inc. | $16.10 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117366564 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.30 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104510050 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.15 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105558124 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.70 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105343727 | CMS |
| Lilly USA, LLC | $19.79 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135033706 | CMS |
| Lilly USA, LLC | $18.99 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135009143 | CMS |
| Novo Nordisk Inc | $22.59 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097836450 | CMS |
| Novo Nordisk Inc | $19.58 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096966633 | CMS |
| PFIZER INC. | $33.29 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130878466 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.14 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139879403 | CMS |
| SANOFI-AVENTIS U.S. LLC | $28.77 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139879453 | CMS |
| SHIELD THERAPEUTICS INC | $19.39 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150116421 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.